Clinical feasibility of radiofrequency ablation using novel adjustable separable electrodes with a multipurpose needle for treating small hepatocellular carcinomas: a prospective single center study

References

• Xu Q, Kobayashi S, Ye X, et al. Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep. 2014;4:7252. doi: 10.1038/srep07252.
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, et al. European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Korean Liver Cancer Association (KLCA), National Cancer Center (NCC). Korean liver cancer association–national cancer center Korea practice guidelines for the management of hepatocellular carcinoma. Korean J Radiol. 2018;20:1042–1113.
   Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi: 10.1016/j.jhep.2021.11.018.
   PubMed Web of Science ®Google Scholar
• Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2022;11(3):209–218. doi: 10.1159/000521665.
   PubMed Web of Science ®Google Scholar
• Lee MW, Kang D, Lim HK, et al. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma< 3 cm: emphasis on association of local tumor progression and overall survival. Eur Radiol. 2020;30(4):2391–2400. doi: 10.1007/s00330-019-06575-0.
   PubMed Web of Science ®Google Scholar
• Lee DH, Kim JW, Lee JM, et al. Laparoscopic liver resection versus percutaneous radiofrequency ablation for small single nodular hepatocellular carcinoma: comparison of treatment outcomes. Liver Cancer. 2021;10(1):25–37. doi: 10.1159/000510909.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Kang TW, et al. Clinical outcomes of radiofrequency ablation for early hypovascular HCC: a multicenter retrospective study. Radiology. 2018;286(1):338–349. doi: 10.1148/radiol.2017162452.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Y, Zhou B, et al. Challenges facing percutaneous ablation in the treatment of hepatocellular carcinoma: extension of ablation criteria. J Hepatocell Carcinoma. 2021;8:625–644. doi: 10.2147/JHC.S298709.
   PubMed Web of Science ®Google Scholar
• Kim KW, Lee JM, Klotz E, et al. Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol. 2011;196(5):W565–W572. doi: 10.2214/AJR.10.5122.
   PubMed Web of Science ®Google Scholar
• Teng W, Liu KW, Lin CC, et al. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation. Liver Cancer. 2015;4(1):26–38. doi: 10.1159/000343877.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of Colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175. doi: 10.1007/s00270-012-0377-1.
   PubMed Web of Science ®Google Scholar
• Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–577; quiz 578. doi: 10.1038/ajg.2011.425.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58(1):89–97. doi: 10.1016/j.jhep.2012.09.020.
   PubMed Web of Science ®Google Scholar
• Lee JM, Han JK, Kim SH, et al. Wet radio-frequency ablation using multiple electrodes: comparative study of bipolar versus monopolar modes in the bovine liver. Eur J Radiol. 2005;54(3):408–417. doi: 10.1016/j.ejrad.2004.06.004.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Brace CL, Lee FT, Jr., et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369. doi: 10.1148/radiol.10081634.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JM, Yoon JH, et al. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol. 2012;13(1):34–43. doi: 10.3348/kjr.2012.13.1.34.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, real-time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19(4):545–559. doi: 10.3348/kjr.2018.19.4.545.
   PubMed Web of Science ®Google Scholar
• Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S179–S186. doi: 10.1016/j.jvir.2010.04.008.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wen F, Guo Q, et al. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol. 2013;25(2):187–194. doi: 10.1097/MEG.0b013e32835a0a07.
   PubMed Web of Science ®Google Scholar
• Chen QW, Ying HF, Gao S, et al. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2016;40(3):309–314. doi: 10.1016/j.clinre.2015.07.008.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee MW, Kim PN, et al. Outcome of no-touch radiofrequency ablation for small hepatocellular carcinoma: a multicenter clinical trial. Radiology. 2021;301(1):229–236. doi: 10.1148/radiol.2021210309.
   PubMed Web of Science ®Google Scholar
• Lu DE, Cheng SW, Lin YS, et al. Combination of radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis. Ann Hepatol. 2022;27(5):100729. doi: 10.1016/j.aohep.2022.100729.
   PubMed Web of Science ®Google Scholar
• Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89(10):1206–1222. doi: 10.1046/j.1365-2168.2002.02168.x.
   PubMed Web of Science ®Google Scholar
• Park S-J, Lee JM, Kim JH, et al. Comparison of ablation performance between octopus multipurpose electrode versus conventional octopus electrode. Korean J Radiol. 2023;24(2):86–94. doi: 10.3348/kjr.2022.0600.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–354. doi: 10.1016/j.jhep.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Song I, Rhim H, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19(11):2630–2640. doi: 10.1007/s00330-009-1463-x.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Lee JM, Klotz E, et al. Prediction of local tumor progression after radiofrequency ablation (RFA) of hepatocellular carcinoma by assessment of ablative margin using pre-RFA MRI and post-RFA CT registration. Korean J Radiol. 2018;19(6):1053–1065. doi: 10.3348/kjr.2018.19.6.1053.
   PubMed Web of Science ®Google Scholar
• Shropshire EL, Chaudhry M, Miller CM, et al. LI-RADS treatment response algorithm: performance and diagnostic accuracy. Radiology. 2019;292(1):226–234. doi: 10.1148/radiol.2019182135.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• Cha J, Kim YS, Rhim H, et al. Radiofrequency ablation using a new type of internally cooled electrode with an adjustable active tip: an experimental study in ex vivo bovine and in vivo porcine livers. Eur J Radiol. 2011;77(3):516–521. doi: 10.1016/j.ejrad.2009.09.011.
   PubMed Web of Science ®Google Scholar
• Kotoh K, Morizono S, Kohjima M, et al. Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model. Liver Int. 2005;25(6):1217–1223. doi: 10.1111/j.1478-3231.2005.01167.x.
   PubMed Web of Science ®Google Scholar
• Kim KA, Kim MJ, Jeon HM, et al. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium‐enhanced hepatobiliary phase images. J Magn Reson Imaging. 2012;35(3):629–634. doi: 10.1002/jmri.22876.
   PubMed Web of Science ®Google Scholar
• Hirooka M, Hiraoka A, Ochi H, et al. Prospective cohort trial to confirm the efficacy of no-touch radio frequency ablation. J Gastroenterol Hepatol. 2019;34(3):567–574. doi: 10.1111/jgh.14476.
   PubMed Web of Science ®Google Scholar
• Kawamura Y, Ikeda K, Shindoh J, et al. No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection. Hepatol Res. 2019;49(2):164–176. doi: 10.1111/hepr.13254.
   PubMed Web of Science ®Google Scholar
• Park SJ, Cho EJ, Lee JH, et al. Switching monopolar no-touch radiofrequency ablation using octopus electrodes for small hepatocellular carcinoma: a randomized clinical trial. Liver Cancer. 2021;10(1):72–81. doi: 10.1159/000512338.
   PubMed Web of Science ®Google Scholar
• Kim TH, Choi HI, Kim BR, et al. No-touch radiofrequency ablation of VX2 hepatic tumors in vivo in rabbits: a proof of concept study. Korean J Radiol. 2018;19(6):1099–1109. doi: 10.3348/kjr.2018.19.6.1099.
   PubMed Web of Science ®Google Scholar
• Rhim H, Dodd GD, 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24(1):41–52. doi: 10.1148/rg.241025144.
   PubMed Web of Science ®Google Scholar